Human NR5A1/SF-1 mutations show decreased activity on BDNF (brain-derived neurotrophic factor), an important regulator of energy balance: testing impact of novel SF-1 mutations beyond steroidogenesis.

Human NR5A1/SF-1 mutations cause 46,XY disorder of sex development (DSD) with broad phenotypic variability, and rarely cause adrenal insufficiency although SF-1 is an important transcription factor for many genes involved in steroidogenesis. In addition, the Sf-1 knockout mouse develops obesity with...

Full description

Bibliographic Details
Main Authors: Jana Malikova, Núria Camats, Mónica Fernández-Cancio, Karen Heath, Isabel González, María Caimarí, Miguel del Campo, Marian Albisu, Stanislava Kolouskova, Laura Audí, Christa E Flück
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4133263?pdf=render
_version_ 1818525208366022656
author Jana Malikova
Núria Camats
Mónica Fernández-Cancio
Karen Heath
Isabel González
María Caimarí
Miguel del Campo
Marian Albisu
Stanislava Kolouskova
Laura Audí
Christa E Flück
author_facet Jana Malikova
Núria Camats
Mónica Fernández-Cancio
Karen Heath
Isabel González
María Caimarí
Miguel del Campo
Marian Albisu
Stanislava Kolouskova
Laura Audí
Christa E Flück
author_sort Jana Malikova
collection DOAJ
description Human NR5A1/SF-1 mutations cause 46,XY disorder of sex development (DSD) with broad phenotypic variability, and rarely cause adrenal insufficiency although SF-1 is an important transcription factor for many genes involved in steroidogenesis. In addition, the Sf-1 knockout mouse develops obesity with age. Obesity might be mediated through Sf-1 regulating activity of brain-derived neurotrophic factor (BDNF), an important regulator of energy balance in the ventromedial hypothalamus.To characterize novel SF-1 gene variants in 4 families, clinical, genetic and functional studies were performed with respect to steroidogenesis and energy balance.5 patients with 46,XY DSD were found to harbor NR5A1/SF-1 mutations including 2 novel variations. One patient harboring a novel mutation also suffered from adrenal insufficiency.SF-1 mutations were studied in cell systems (HEK293, JEG3) for impact on transcription of genes involved in steroidogenesis (CYP11A1, CYP17A1, HSD3B2) and in energy balance (BDNF). BDNF regulation by SF-1 was studied by promoter assays (JEG3).Two novel NR5A1/SF-1 mutations (Glu7Stop, His408Profs*159) were confirmed. Glu7Stop is the 4th reported SF-1 mutation causing DSD and adrenal insufficiency. In vitro studies revealed that transcription of the BDNF gene is regulated by SF-1, and that mutant SF-1 decreased BDNF promoter activation (similar to steroid enzyme promoters). However, clinical data from 16 subjects carrying SF-1 mutations showed normal birth weight and BMI.Glu7Stop and His408Profs*159 are novel SF-1 mutations identified in patients with 46,XY DSD and adrenal insufficiency (Glu7Stop). In vitro, SF-1 mutations affect not only steroidogenesis but also transcription of BDNF which is involved in energy balance. However, in contrast to mice, consequences on weight were not found in humans with SF-1 mutations.
first_indexed 2024-12-11T06:06:32Z
format Article
id doaj.art-ed8db0b77dc64bc6ba506d50bb9995e1
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-11T06:06:32Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-ed8db0b77dc64bc6ba506d50bb9995e12022-12-22T01:18:17ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0198e10483810.1371/journal.pone.0104838Human NR5A1/SF-1 mutations show decreased activity on BDNF (brain-derived neurotrophic factor), an important regulator of energy balance: testing impact of novel SF-1 mutations beyond steroidogenesis.Jana MalikovaNúria CamatsMónica Fernández-CancioKaren HeathIsabel GonzálezMaría CaimaríMiguel del CampoMarian AlbisuStanislava KolouskovaLaura AudíChrista E FlückHuman NR5A1/SF-1 mutations cause 46,XY disorder of sex development (DSD) with broad phenotypic variability, and rarely cause adrenal insufficiency although SF-1 is an important transcription factor for many genes involved in steroidogenesis. In addition, the Sf-1 knockout mouse develops obesity with age. Obesity might be mediated through Sf-1 regulating activity of brain-derived neurotrophic factor (BDNF), an important regulator of energy balance in the ventromedial hypothalamus.To characterize novel SF-1 gene variants in 4 families, clinical, genetic and functional studies were performed with respect to steroidogenesis and energy balance.5 patients with 46,XY DSD were found to harbor NR5A1/SF-1 mutations including 2 novel variations. One patient harboring a novel mutation also suffered from adrenal insufficiency.SF-1 mutations were studied in cell systems (HEK293, JEG3) for impact on transcription of genes involved in steroidogenesis (CYP11A1, CYP17A1, HSD3B2) and in energy balance (BDNF). BDNF regulation by SF-1 was studied by promoter assays (JEG3).Two novel NR5A1/SF-1 mutations (Glu7Stop, His408Profs*159) were confirmed. Glu7Stop is the 4th reported SF-1 mutation causing DSD and adrenal insufficiency. In vitro studies revealed that transcription of the BDNF gene is regulated by SF-1, and that mutant SF-1 decreased BDNF promoter activation (similar to steroid enzyme promoters). However, clinical data from 16 subjects carrying SF-1 mutations showed normal birth weight and BMI.Glu7Stop and His408Profs*159 are novel SF-1 mutations identified in patients with 46,XY DSD and adrenal insufficiency (Glu7Stop). In vitro, SF-1 mutations affect not only steroidogenesis but also transcription of BDNF which is involved in energy balance. However, in contrast to mice, consequences on weight were not found in humans with SF-1 mutations.http://europepmc.org/articles/PMC4133263?pdf=render
spellingShingle Jana Malikova
Núria Camats
Mónica Fernández-Cancio
Karen Heath
Isabel González
María Caimarí
Miguel del Campo
Marian Albisu
Stanislava Kolouskova
Laura Audí
Christa E Flück
Human NR5A1/SF-1 mutations show decreased activity on BDNF (brain-derived neurotrophic factor), an important regulator of energy balance: testing impact of novel SF-1 mutations beyond steroidogenesis.
PLoS ONE
title Human NR5A1/SF-1 mutations show decreased activity on BDNF (brain-derived neurotrophic factor), an important regulator of energy balance: testing impact of novel SF-1 mutations beyond steroidogenesis.
title_full Human NR5A1/SF-1 mutations show decreased activity on BDNF (brain-derived neurotrophic factor), an important regulator of energy balance: testing impact of novel SF-1 mutations beyond steroidogenesis.
title_fullStr Human NR5A1/SF-1 mutations show decreased activity on BDNF (brain-derived neurotrophic factor), an important regulator of energy balance: testing impact of novel SF-1 mutations beyond steroidogenesis.
title_full_unstemmed Human NR5A1/SF-1 mutations show decreased activity on BDNF (brain-derived neurotrophic factor), an important regulator of energy balance: testing impact of novel SF-1 mutations beyond steroidogenesis.
title_short Human NR5A1/SF-1 mutations show decreased activity on BDNF (brain-derived neurotrophic factor), an important regulator of energy balance: testing impact of novel SF-1 mutations beyond steroidogenesis.
title_sort human nr5a1 sf 1 mutations show decreased activity on bdnf brain derived neurotrophic factor an important regulator of energy balance testing impact of novel sf 1 mutations beyond steroidogenesis
url http://europepmc.org/articles/PMC4133263?pdf=render
work_keys_str_mv AT janamalikova humannr5a1sf1mutationsshowdecreasedactivityonbdnfbrainderivedneurotrophicfactoranimportantregulatorofenergybalancetestingimpactofnovelsf1mutationsbeyondsteroidogenesis
AT nuriacamats humannr5a1sf1mutationsshowdecreasedactivityonbdnfbrainderivedneurotrophicfactoranimportantregulatorofenergybalancetestingimpactofnovelsf1mutationsbeyondsteroidogenesis
AT monicafernandezcancio humannr5a1sf1mutationsshowdecreasedactivityonbdnfbrainderivedneurotrophicfactoranimportantregulatorofenergybalancetestingimpactofnovelsf1mutationsbeyondsteroidogenesis
AT karenheath humannr5a1sf1mutationsshowdecreasedactivityonbdnfbrainderivedneurotrophicfactoranimportantregulatorofenergybalancetestingimpactofnovelsf1mutationsbeyondsteroidogenesis
AT isabelgonzalez humannr5a1sf1mutationsshowdecreasedactivityonbdnfbrainderivedneurotrophicfactoranimportantregulatorofenergybalancetestingimpactofnovelsf1mutationsbeyondsteroidogenesis
AT mariacaimari humannr5a1sf1mutationsshowdecreasedactivityonbdnfbrainderivedneurotrophicfactoranimportantregulatorofenergybalancetestingimpactofnovelsf1mutationsbeyondsteroidogenesis
AT migueldelcampo humannr5a1sf1mutationsshowdecreasedactivityonbdnfbrainderivedneurotrophicfactoranimportantregulatorofenergybalancetestingimpactofnovelsf1mutationsbeyondsteroidogenesis
AT marianalbisu humannr5a1sf1mutationsshowdecreasedactivityonbdnfbrainderivedneurotrophicfactoranimportantregulatorofenergybalancetestingimpactofnovelsf1mutationsbeyondsteroidogenesis
AT stanislavakolouskova humannr5a1sf1mutationsshowdecreasedactivityonbdnfbrainderivedneurotrophicfactoranimportantregulatorofenergybalancetestingimpactofnovelsf1mutationsbeyondsteroidogenesis
AT lauraaudi humannr5a1sf1mutationsshowdecreasedactivityonbdnfbrainderivedneurotrophicfactoranimportantregulatorofenergybalancetestingimpactofnovelsf1mutationsbeyondsteroidogenesis
AT christaefluck humannr5a1sf1mutationsshowdecreasedactivityonbdnfbrainderivedneurotrophicfactoranimportantregulatorofenergybalancetestingimpactofnovelsf1mutationsbeyondsteroidogenesis